Latest Updates
Read the latest news that impacts the oncology community.
HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors
Published On: January 17th, 2025Today, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations.
Why not tie Medicare payments to inflation?
Published On: January 17th, 2025The Medicare Payment Advisory Commission on Jan. 16 voted to recommend tying next year's Medicare physician payment update to the growth in care costs.
Optum Rx commits to passing through 100% of drug rebates, Witty says
Published On: January 17th, 2025UnitedHealth Group's Optum Rx unit made a commitment to pass through 100% of rebates negotiated with drugmakers to the client.
Healthcare in the Mix in President Biden’s Farewell Address
Published On: January 17th, 2025In a brief and somber farewell address to the nation on Wednesday night, President Biden touched on a number of his administration's accomplishments in healthcare as he summed up his time in office.
Cancer statistics, 2025
Published On: January 17th, 2025Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collected by the National Center for Health Statistics (through 2022).
Young women are almost twice as likely to be diagnosed with cancer as young men: ‘We’re seeing a change’
Published On: January 17th, 2025CNN — Charmella Roark remembers the shock that stopped her in her tracks when she learned about her younger sister’s cancer diagnosis.
Trump’s plans for HHS: 13 knowns
Published On: January 16th, 2025President-elect Donald Trump's HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems.
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
Published On: January 16th, 2025For the second time in less than a year, the Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain.
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
Published On: January 16th, 2025Maricruz Salgado was bringing her diabetes under control. Thanks to a federal program that allowed health clinics that serve poor people to buy drugs at steeply discounted prices, she was able to pay less than $75 for all five of her diabetes medications every three months.
The Exec: PBGH’s Elizabeth Mitchell on Transparency, Costs, and Employer Empowerment
Published On: January 16th, 2025Employers face tremendous pressure to offer affordable, quality healthcare for their employees. This is particularly true for self-insured employers who pay their own healthcare claims.
